MXPA03002629A - Analogos de acido graso para el tratamiento de enfermedades proliferativas de la piel. - Google Patents

Analogos de acido graso para el tratamiento de enfermedades proliferativas de la piel.

Info

Publication number
MXPA03002629A
MXPA03002629A MXPA03002629A MXPA03002629A MXPA03002629A MX PA03002629 A MXPA03002629 A MX PA03002629A MX PA03002629 A MXPA03002629 A MX PA03002629A MX PA03002629 A MXPA03002629 A MX PA03002629A MX PA03002629 A MXPA03002629 A MX PA03002629A
Authority
MX
Mexico
Prior art keywords
carbon
ohgr
alkyl
fatty acid
treatment
Prior art date
Application number
MXPA03002629A
Other languages
English (en)
Spanish (es)
Inventor
Rolf Berge
Original Assignee
Thia Medica As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thia Medica As filed Critical Thia Medica As
Publication of MXPA03002629A publication Critical patent/MXPA03002629A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/08Antiseborrheics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/12Keratolytics, e.g. wart or anti-corn preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/16Emollients or protectives, e.g. against radiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Toxicology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MXPA03002629A 2000-09-27 2001-09-27 Analogos de acido graso para el tratamiento de enfermedades proliferativas de la piel. MXPA03002629A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NO20004844A NO20004844L (no) 2000-09-27 2000-09-27 Fettsyre analoger for behandling av proliferative hudsykdommer
PCT/NO2001/000393 WO2002026218A2 (en) 2000-09-27 2001-09-27 Fatty acid analogues for the treatment of proliferative skin disorders

Publications (1)

Publication Number Publication Date
MXPA03002629A true MXPA03002629A (es) 2004-05-24

Family

ID=19911618

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03002629A MXPA03002629A (es) 2000-09-27 2001-09-27 Analogos de acido graso para el tratamiento de enfermedades proliferativas de la piel.

Country Status (16)

Country Link
US (1) US7230029B2 (enExample)
EP (1) EP1324756B1 (enExample)
JP (1) JP2004509917A (enExample)
KR (1) KR100905336B1 (enExample)
CN (1) CN100579521C (enExample)
AT (1) ATE418974T1 (enExample)
AU (2) AU2001294419B2 (enExample)
BR (1) BR0114137A (enExample)
CA (1) CA2421729A1 (enExample)
DE (1) DE60137243D1 (enExample)
ES (1) ES2317938T3 (enExample)
MX (1) MXPA03002629A (enExample)
NO (1) NO20004844L (enExample)
NZ (1) NZ524599A (enExample)
RU (1) RU2276602C2 (enExample)
WO (1) WO2002026218A2 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO328803B1 (no) 2000-03-03 2010-05-18 Thia Medica Nye fettsyreanaloger
JP5008258B2 (ja) 2002-06-20 2012-08-22 アイシー・ベック・リミテッド 含硫黄ホスホリピド誘導体
FR2850869B1 (fr) * 2003-02-12 2005-03-25 Genfit S A Utilisations d'aminopropanediols acyles et de leurs analogues azotes et sulfures
ES2660700T3 (es) * 2004-07-19 2018-03-23 Bergen Teknologioverføring As Composición que comprende aceites vegetales y/o de pescado y entidades de ácidos grasos no oxidables
EP2120916A4 (en) * 2007-02-05 2010-07-28 Children Youth And Women S Hea MODULATORS FOR THE PROLIFERATION OF T CELLS DEPENDENT OF ANTIGEN
US8602833B2 (en) 2009-08-06 2013-12-10 May Patents Ltd. Puzzle with conductive path
US11330714B2 (en) 2011-08-26 2022-05-10 Sphero, Inc. Modular electronic building systems with magnetic interconnections and methods of using the same
US9019718B2 (en) 2011-08-26 2015-04-28 Littlebits Electronics Inc. Modular electronic building systems with magnetic interconnections and methods of using the same
US9597607B2 (en) 2011-08-26 2017-03-21 Littlebits Electronics Inc. Modular electronic building systems with magnetic interconnections and methods of using the same
USD732475S1 (en) 2012-11-19 2015-06-23 Littlebits Electronics Inc. Connector for modular electronic building system
AU2014229506B2 (en) 2013-03-11 2017-04-13 Nobesita As Natural lipids containing non-oxidizable fatty acids
CN105498622B (zh) * 2015-12-10 2017-10-17 江南大学 一种含硒表面活性剂及其制备方法和应用
WO2018065918A1 (en) 2016-10-04 2018-04-12 Mary Kay Inc. Methods and compositions for treating striae distensae
AU2019340475B2 (en) * 2018-09-14 2025-04-17 Université de Lausanne Methods for modulating regulatory T cells and inhibiting tumor growth

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU618517B2 (en) * 1986-12-23 1992-01-02 Eugene J. Van Scott Additives enhancing topical actions of therapeutic agents
DE19516705C2 (de) * 1995-05-06 1997-10-02 Beiersdorf Ag Gegen Bakterien, Mycota und Viren wirksame Substanzen
RU2123334C1 (ru) * 1997-03-05 1998-12-20 Тихоокеанский научно-исследовательский рыбохозяйственный центр Способ лечения псориаза
AU7240398A (en) * 1998-05-08 1999-11-29 Rolf Berge Use of non-beta-oxidizable fatty acid analogues for treatment of syndrome-x conditions
FR2792312B1 (fr) * 1999-04-15 2001-06-08 Oreal Composes (poly)thia-alcynoiques et leurs derives, compositions les comprenant et leur utilisation
AUPQ291499A0 (en) * 1999-09-17 1999-10-07 Women's And Children's Hospital Adelaide Novel nitro and sulphur containing compounds
NO328803B1 (no) * 2000-03-03 2010-05-18 Thia Medica Nye fettsyreanaloger

Also Published As

Publication number Publication date
ES2317938T3 (es) 2009-05-01
EP1324756B1 (en) 2008-12-31
US7230029B2 (en) 2007-06-12
NO20004844D0 (no) 2000-09-27
WO2002026218A2 (en) 2002-04-04
AU2001294419B2 (en) 2005-12-01
ATE418974T1 (de) 2009-01-15
JP2004509917A (ja) 2004-04-02
BR0114137A (pt) 2003-08-12
CA2421729A1 (en) 2002-04-04
NO20004844L (no) 2002-05-10
KR20030036843A (ko) 2003-05-09
KR100905336B1 (ko) 2009-07-01
CN1466453A (zh) 2004-01-07
RU2276602C2 (ru) 2006-05-20
US20040019108A1 (en) 2004-01-29
DE60137243D1 (de) 2009-02-12
WO2002026218A3 (en) 2002-06-13
HK1060692A1 (zh) 2004-08-20
CN100579521C (zh) 2010-01-13
NZ524599A (en) 2004-11-26
EP1324756A2 (en) 2003-07-09
AU9441901A (en) 2002-04-08

Similar Documents

Publication Publication Date Title
MXPA03002629A (es) Analogos de acido graso para el tratamiento de enfermedades proliferativas de la piel.
MXPA02012944A (es) Analogos de acido graso para el tratamiento de cancer.
PT1075259E (pt) Novos analogos gordos para o tratamento de diabetes
MXPA04004837A (es) Inhibidores de 11-??-hidroxiesteroide deshidrogenasa de tipo 1.
IL161154A0 (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
CA2185489A1 (en) Cyclic adhesion inhibitors
MXPA02008629A (es) Nuevos analogos de acidos grasos.
EP0911331A3 (en) Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
TW364850B (en) Nematocidal compositions
MXPA03004427A (es) Analogos de acido graso para el tratamiento de desordenes inflamatorios y autoinmunes.
BR9609041A (pt) "terapia de substituição para cáries dentais".
AUPR626101A0 (en) A composition and uses therefor
PL316656A1 (en) Free halophantrin base for use in treating marsh-fever and compositions containing same
AU2634597A (en) Compounds with growth hormone releasing properties
HK21192A (en) Peptic ulcer treatment
AR020832A1 (es) Procedimiento para la preparacion de una composicion de alta pureza de (7alfa, 17alfa)-17-hidroxi-7-metil-19-nor-17-pregn-5-(10)-en-20-in-3-ona
GB0105837D0 (en) Pharmaceutical compositions including alginates
AU4630599A (en) Perfume composition
CY1107756T1 (el) Αναλογα θειου της 21-υδροξυ-6, 19-οξειδοπρογεστερονης (21oh-6οp) για τη θεραπεια πλεονασματος γλυκοκορτικοειδων
MY135472A (en) Oil-barrier composition
MXPA02006725A (es) Analogos de vitamina d novedosos.
MXPA05006378A (es) Compuestos esteroides con actividad anti-tumoral.
SI1572726T1 (sl) 4-metilheksanoiäśna kahalalid f spojina

Legal Events

Date Code Title Description
FG Grant or registration